Table 4:

Relationship between longitudinal bicarbonate levels and all-cause mortality in the transition-CKD population.

Q SBCaEvents, N (%)Person time, yearsEvents for 1000 person-yearsUnadjusted, HR (95% CI)Sex, age, HR (95% CI)bBMI, albumin, SGA, HR (95% CI)beGFR, K+, HR (95% CI)bComorbidities, primary renal disease, HR (95% CI)b
1st60 (39.0)474.01270.82 (0.54, 1.23); P = .3360.84 (0.56, 1.26); P = .3910.86 (0.57, 1.29); P = .4580.87 (0.58, 1.32); P = .5140.88 (0.57, 1.36); P = .572
2nd39 (28.9)489.4800.76 (0.5, 1.15); P = .1880.74 (0.49, 1.13); P = .1610.85 (0.56, 1.29); P = .4510.86 (0.57, 1.31); P = .4850.9 (0.59, 1.39); P = .640
3rd40 (36.0)386.11041.00 (Reference)1.00 (Reference)1.00 (Reference)1.00 (Reference)1.00 (Reference)
4th38 (37.3)355.71071.05 (0.71, 1.55); P = .8191.05 (0.71, 1.57); P = .7910.92 (0.61, 1.39); P = .6870.89 (0.59, 1.36); P = .6010.92 (0.61, 1.38); P = .685
Q SBCaEvents, N (%)Person time, yearsEvents for 1000 person-yearsUnadjusted, HR (95% CI)Sex, age, HR (95% CI)bBMI, albumin, SGA, HR (95% CI)beGFR, K+, HR (95% CI)bComorbidities, primary renal disease, HR (95% CI)b
1st60 (39.0)474.01270.82 (0.54, 1.23); P = .3360.84 (0.56, 1.26); P = .3910.86 (0.57, 1.29); P = .4580.87 (0.58, 1.32); P = .5140.88 (0.57, 1.36); P = .572
2nd39 (28.9)489.4800.76 (0.5, 1.15); P = .1880.74 (0.49, 1.13); P = .1610.85 (0.56, 1.29); P = .4510.86 (0.57, 1.31); P = .4850.9 (0.59, 1.39); P = .640
3rd40 (36.0)386.11041.00 (Reference)1.00 (Reference)1.00 (Reference)1.00 (Reference)1.00 (Reference)
4th38 (37.3)355.71071.05 (0.71, 1.55); P = .8191.05 (0.71, 1.57); P = .7910.92 (0.61, 1.39); P = .6870.89 (0.59, 1.36); P = .6010.92 (0.61, 1.38); P = .685

Time-dependent Cox regression model; overall study population N = 502.

aQuartiles of serum bicarbonate; SBC, BMI, albumin, SGA, K+ and eGFR treated as time-varying covariates.

bHR and 95% CI adjusted sequentially for confounders (sex, age, BMI, SGA, eGFR, K+, comorbidities, primary renal disease).

Table 4:

Relationship between longitudinal bicarbonate levels and all-cause mortality in the transition-CKD population.

Q SBCaEvents, N (%)Person time, yearsEvents for 1000 person-yearsUnadjusted, HR (95% CI)Sex, age, HR (95% CI)bBMI, albumin, SGA, HR (95% CI)beGFR, K+, HR (95% CI)bComorbidities, primary renal disease, HR (95% CI)b
1st60 (39.0)474.01270.82 (0.54, 1.23); P = .3360.84 (0.56, 1.26); P = .3910.86 (0.57, 1.29); P = .4580.87 (0.58, 1.32); P = .5140.88 (0.57, 1.36); P = .572
2nd39 (28.9)489.4800.76 (0.5, 1.15); P = .1880.74 (0.49, 1.13); P = .1610.85 (0.56, 1.29); P = .4510.86 (0.57, 1.31); P = .4850.9 (0.59, 1.39); P = .640
3rd40 (36.0)386.11041.00 (Reference)1.00 (Reference)1.00 (Reference)1.00 (Reference)1.00 (Reference)
4th38 (37.3)355.71071.05 (0.71, 1.55); P = .8191.05 (0.71, 1.57); P = .7910.92 (0.61, 1.39); P = .6870.89 (0.59, 1.36); P = .6010.92 (0.61, 1.38); P = .685
Q SBCaEvents, N (%)Person time, yearsEvents for 1000 person-yearsUnadjusted, HR (95% CI)Sex, age, HR (95% CI)bBMI, albumin, SGA, HR (95% CI)beGFR, K+, HR (95% CI)bComorbidities, primary renal disease, HR (95% CI)b
1st60 (39.0)474.01270.82 (0.54, 1.23); P = .3360.84 (0.56, 1.26); P = .3910.86 (0.57, 1.29); P = .4580.87 (0.58, 1.32); P = .5140.88 (0.57, 1.36); P = .572
2nd39 (28.9)489.4800.76 (0.5, 1.15); P = .1880.74 (0.49, 1.13); P = .1610.85 (0.56, 1.29); P = .4510.86 (0.57, 1.31); P = .4850.9 (0.59, 1.39); P = .640
3rd40 (36.0)386.11041.00 (Reference)1.00 (Reference)1.00 (Reference)1.00 (Reference)1.00 (Reference)
4th38 (37.3)355.71071.05 (0.71, 1.55); P = .8191.05 (0.71, 1.57); P = .7910.92 (0.61, 1.39); P = .6870.89 (0.59, 1.36); P = .6010.92 (0.61, 1.38); P = .685

Time-dependent Cox regression model; overall study population N = 502.

aQuartiles of serum bicarbonate; SBC, BMI, albumin, SGA, K+ and eGFR treated as time-varying covariates.

bHR and 95% CI adjusted sequentially for confounders (sex, age, BMI, SGA, eGFR, K+, comorbidities, primary renal disease).

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close